General Information

The information on these pages should be used to research health risks and to inform the pre-travel consultation.

Travellers should check the Foreign, Commonwealth & Development Office (FCDO) country-specific travel advice page (where available) which provides information on travel entry requirements in addition to safety and security advice.

Travellers should ideally arrange an appointment with their health professional at least four to six weeks before travel. However, even if time is short, an appointment is still worthwhile. This appointment provides an opportunity to assess health risks taking into account a number of factors including destination, medical history, and planned activities. For those with pre-existing health problems, an earlier appointment is recommended.

All travellers should ensure they have adequate travel health insurance.

If visiting European Union (EU) and/or European Economic Area (EEA) countries, carry an European Health Insurance Card (EHIC) or a Global Health Insurance Card (GHIC) as this will allow access to necessary state-provided healthcare in some countries on the same basis as a resident of that country. This may be free or it may require a payment equivalent to that which a local resident would pay. The EHIC and GHIC, however, are not alternatives to travel insurance. Check the NHS website for guidance.

A list of useful resources including advice on how to reduce the risk of certain health problems is available below.

Resources

Vaccine Recommendations

Details of vaccination recommendations and requirements are provided below.

All travellers

Travellers should be up to date with routine vaccination courses and boosters as recommended in the UK according to their age, medical history and individual risks.

The travel health consultation provides an opportunity to check whether routine immunisations are up to date such as MMR/MMRV and diphtheria-tetanus-polio vaccines. The following link provides information on the current recommended immunisation schedule recommended in the UK.

Country-specific diphtheria recommendations are not provided here. Diphtheria, tetanus and polio are combined in a single vaccine in the UK. Therefore, when a tetanus booster is recommended for travellers, diphtheria vaccine is also given. In the event of a diphtheria outbreak in a country, specific diphtheria vaccination guidance will be provided.

For individuals with an uncertain or incomplete immunisation history please find guidance for health professionals here Vaccination of individuals with uncertain or incomplete immunisation.

UKHSA provide an immunisation comparison tool for individuals who may have been vaccinated overseas UK and international immunisation schedules comparison tool.

Those who may be at increased risk of an infectious disease due to their work, lifestyle choice, or certain underlying health problems should be up to date with additional recommended vaccines. See vaccine recommendations for these groups at the bottom of the 'Complete routine immunisation schedule' document. The individual disease chapters of the 'Green Book' Immunisation against infectious disease provides further details.

Certificate requirements

There are no certificate requirements under International Health Regulations.

Most travellers

The vaccines in this section are recommended for most travellers visiting this country. Information on these vaccines can be found by clicking on the blue arrow. Vaccines are listed alphabetically.

Tetanus is caused by a toxin released from Clostridium tetani bacteria and occurs worldwide. Tetanus bacteria are present in soil and manure and may be introduced through open wounds such as a puncture wound, burn or scratch.

Prevention

Travellers should thoroughly clean all wounds and seek medical attention for injuries such as animal bites/scratches, burns or wounds contaminated with soil.

Tetanus vaccination

  • Travellers should have completed a tetanus vaccination course according to the UK schedule.
  • If travelling to a country or area where medical facilities may be limited, a booster dose of a tetanus-containing vaccine is recommended if the last dose was more than ten years ago even if five doses of vaccine have been given previously.

Country-specific information on medical facilities may be found in the 'health' section of the FCDO foreign travel advice pages.

Tetanus in brief

Some travellers

The vaccines in this section are recommended for some travellers visiting this country. Information on when these vaccines should be considered can be found by clicking on the arrow. Vaccines are listed alphabetically.

Although rare, bat lyssaviruses (bat rabies) can be transmitted to humans or other animals following contact with the saliva of an infected bat most often by a bite. The disease can also be transmitted if the saliva of an infected bat gets into open wounds or mucous membranes (such as on the eye, nose or mouth). Bat lyssaviruses can cause disease in humans that is indistinguishable from rabies.

Symptoms can take some time to develop, but when they do the condition is almost always fatal.

The risk to most travellers is low. However, it is increased for certain occupations for example bat handlers and veterinarians, or certain activities such as caving.

Bat Lyssavirus in Italy

Bat rabies has been reported in this country; most travellers are considered to be at low risk. However, bats may carry bat lyssavirus (bat rabies).

Prevention

  • Travellers should avoid contact with bats. Bites from bats are frequently unrecognised. Rabies-like disease caused by bat lyssaviruses is preventable with prompt post-exposure rabies management.
  • Following a possible exposure, wounds should be thoroughly cleansed and an urgent local medical assessment sought, even if the wound appears trivial. Although rabies has not been reported in other animals in this country, it is sensible to seek prompt medical advice if bitten or scratched. It is possible, although very rare for bats to pass rabies like viruses to other animals including pets.
  • Post-exposure treatment and advice should be in accordance with national guidelines.

Rabies vaccination

  • A full course of pre-exposure vaccines simplifies and shortens the course of post-exposure treatment and removes the need for rabies immunoglobulin which is in short supply world-wide.
  • Pre-exposure rabies vaccinations are recommended for those who are at increased risk due to their work (e.g. laboratory staff working with the virus and those working with bats).
  • Pre-exposure vaccines could be considered for those whose activities put them at increased risk of exposure to bats.
Rabies in brief

Tick-borne encephalitis (TBE) is a viral infection spread by the bite of infected ticks. Occasionally cases of TBE occur after consumption of raw (unpasteurised) milk or dairy products from infected animals (e.g. cows, goats and sheep).

Travellers are at increased risk of exposure during outdoor activities in areas of vegetation such as gardens, parks, meadows, woods, forest fringes and glades. This includes urban parks and woodland areas in cities. Ticks are usually most active between early spring and late autumn.

Tick-borne encephalitis in Italy

There is a risk of TBE in some areas of this country. The transmission season varies, however, ticks are most active during early spring to late autumn.

Cases have been reported in Emilia-Romagna, Friuli-Venezia Giulia, Lazio, Lombardy, Puglia, Trentino-Alto Adige and Veneto.

Prevention

All travellers should avoid tick bites during outdoor activities, apply insect repellent frequently and follow tick bite avoidance advice.

Travellers should check their skin and clothes regularly for ticks and remove them as soon as possible with a recommended technique. Wearing light coloured clothes makes it easier to spot ticks.

Travellers should not eat or drink any unpasteurised milk products.

Tick-borne encephalitis vaccination

Vaccination is recommended for those visiting affected areas whose activities put them at increased risk including:

  • Living in TBE risk areas.
  • Working in forestry, woodcutting, farming and the military.
  • Visiting forested areas and urban parks, e.g. camping, fieldwork, hiking and hunting.
  • Laboratory workers who may be exposed to TBE.
Tick-borne encephalitis in brief

Other Risks

There are some risks that are relevant to all travellers regardless of destination. These may for example include road traffic and other accidents, diseases transmitted by insects or ticks, diseases transmitted by contaminated food and water, or health issues related to the heat or cold.

Some additional risks (which may be present in all or part of this country) are mentioned below and are presented alphabetically. Select risk to expand information.

There is a risk of altitude illness when travelling to destinations of 2,500 metres (8,200 feet) or higher. Important risk factors are the altitude gained, rate of ascent and sleeping altitude. Rapid ascent without a period of acclimatisation puts a traveller at higher risk.

There are three syndromes; acute mountain sickness (AMS), high-altitude cerebral oedema (HACE) and high-altitude pulmonary oedema (HAPE). HACE and HAPE require immediate descent and medical treatment.

Altitude illness in Italy

There is a point of elevation in this country higher than 2,500 metres.

Prevention

  • Travellers should spend a few days at an altitude below 3,000m.
  • Where possible travellers should avoid travel from altitudes less than 1,200m to altitudes greater than 3,500m in a single day.
  • Ascent above 3,000m should be gradual. Travellers should avoid increasing sleeping elevation by more than 500m per day and ensure a rest day (at the same altitude) every three or four days.
  • Acetazolamide can be used to assist with acclimatisation, but should not replace gradual ascent.
  • Travellers who develop symptoms of AMS (headache, fatigue, loss of appetite, nausea and sleep disturbance) should avoid further ascent. In the absence of improvement or with progression of symptoms the first response should be to descend.
  • Development of HACE or HAPE symptoms requires immediate descent and emergency medical treatment.
Altitude illness in brief

Insect or tick bites can cause irritation and infections of the skin at the site of a bite. They can also spread certain diseases.

Diseases in Southern Europe

There is a risk of insect or tick-borne diseases in some areas of Southern Europe. This includes diseases such as Crimean-Congo haemorrhagic fever, leishmaniasis and West Nile virus.

Prevention

  • All travellers should avoid insect and tick bites day and night.
  • There are no vaccinations (or medications) to prevent these diseases.

Further information about specific insect or tick-borne diseases for this country can be found, if appropriate on this page, in other sections of the country information pages and the insect and tick bite avoidance factsheet.

Chikungunya is a viral infection spread by mosquitoes which bite mainly during daytime hours. It causes a flu-like illness and can cause severe joint and muscles pains which usually improve in 1–2 weeks but may persist for months or years. It is rarely fatal.

Chikungunya in Italy

This country has reported chikungunya cases in the past.

Information on current outbreaks, where available, will be reported on our outbreak surveillance database.

Prevention

  • Vaccination is not recommended.
  • Travellers should avoid mosquito bites, particularly during daytime hours.
Chikungunya in brief

Dengue is a viral infection spread by mosquitoes which mainly feed during daytime hours. It causes a flu-like illness, which can occasionally develop into a more serious life-threatening illness. Severe dengue is rare in travellers.

The mosquitoes that spread dengue are more common in towns, cities and surrounding areas.

Dengue in Italy

Dengue has been reported in the Abruzzo, Campania, Emilia-Romagna, Lombardy, Lazio, Marche, Puglia, Tuscany and Veneto regions.

Information on current outbreaks, where available, will be reported on our outbreak surveillance database.

Prevention

  • Vaccination is not recommended.
  • Travellers should avoid mosquito bites, particularly during daytime hours.
Dengue in brief

Seasonal influenza is a viral infection of the respiratory tract and spreads easily from person to person via respiratory droplets when coughing and sneezing. Symptoms appear rapidly and include fever, muscle aches, headache, malaise (feeling unwell), cough, sore throat and a runny nose. In healthy individuals, symptoms improve without treatment within two to seven days. Severe illness is more common in those aged 65 years or over, those under 2 years of age, or those who have underlying medical conditions that increase their risk for complications of influenza.

Seasonal influenza in Italy

Seasonal influenza occurs throughout the world. In the northern hemisphere (including the UK), most influenza occurs from as early as October through to March. In the southern hemisphere, influenza mostly occurs between April and September. In the tropics, influenza can occur throughout the year.

Prevention

All travellers should:

  • Avoid close contact with symptomatic individuals
  • Avoid crowded conditions where possible
  • Wash their hands frequently
  • Practise ‘cough hygiene’: sneezing or coughing into a tissue and promptly discarding it safely, and washing their hands
  • Avoid travel if unwell with influenza-like symptoms
  • A vaccine is available in certain circumstances (see below)*
*In the UK, seasonal influenza vaccine is offered routinely each year to those at higher risk of developing of severe disease following influenza infection, and certain additional groups such as healthcare workers and children as part of the UK national schedule (see information on vaccination). For those who do not fall into these groups, vaccination may be available privately.

If individuals at higher risk of severe disease following influenza infection are travelling to a country when influenza is likely to be circulating they should ensure they received a flu vaccination in the previous 12 months.

The vaccine used in the UK protects against the strains predicted to occur during the winter months of the northern hemisphere. It is not possible to obtain vaccine for the southern hemisphere in the UK, but the vaccine used during the UK influenza season should still provide important protection against strains likely to occur during the southern hemisphere influenza season, and in the tropics.

Avian influenza

Avian influenza viruses can rarely infect and cause disease in humans. Such cases are usually associated with close exposure to infected bird or animal populations. Where appropriate, information on these will be available in the outbreaks and news sections of the relevant country pages. Seasonal influenza vaccines will not provide protection against avian influenza.

Avian influenza in brief

Poor air quality is a significant public health problem in many parts of the world. Exposure to high levels of air pollution over short time periods (e.g. minutes/hours/days) and longer time periods (e.g. years) is linked to many different acute and chronic health problems. These effects are mainly on the respiratory (lungs and airways) and cardiovascular (heart function and blood circulation) systems.

Current information on world air quality is available from the world air quality index project.

Prevention

Travellers with health problems that might make them more vulnerable to the effects of air pollution who are travelling to areas of high pollution should:

  • discuss their travel plans with their doctor, and carry adequate supplies of their regular medication.
  • take sensible precautions to minimise their exposure to high levels of air pollution.
  • check local air quality data and amend their activities accordingly.
  • take notice of any health advisories published by the local Ministry of Health and Department for Environment, and follow the guidance provided.

It is unclear if face masks are beneficial at reducing exposure and may make breathing more difficult for those with pre-existing lung conditions. Those who choose to use one should make sure that the mask fits well and know how to wear it properly.

Outdoor air quality in brief

Sexually transmitted infections (STIs) are a group of viral, bacterial and parasitic infections spread during sexual intercourse or by intimate contact. Certain STIs can be more difficult to treat due to higher levels of antibiotic resistance and some STIs that are rare in the UK may be more common in other world regions.

Anyone who is sexually active is at risk of getting an STI wherever they are in the world.

Risk is higher for travellers who:

  • have sex without a condom
  • have sex with new or casual partners
  • engage in sex tourism
  • have sex under the influence of drugs or alcohol

Symptoms of STIs vary depending on the type of infection; some may only cause mild or unnoticeable symptoms. If symptoms do occur, they can include a rash, discharge, itching, blisters, sores or warts in genital and/or anal areas, pain when peeing and flu like symptoms.

If left untreated, STIs can cause serious long term health issues such as fertility problems, pelvic inflammatory disease and pregnancy complications.

Prevention

Using condoms consistently and correctly with new or casual partners is the most effective way to reduce risk of STIs.

Travellers can also reduce their risk of STIs by:

Travellers should seek medical advice and give their travel history if they think they may have an STI, even if they have no symptoms. They should also have a test for STIs if they have had sex without condoms with a new or casual partner while abroad.

In the UK STI testing is free and confidential.

News

Vector-borne disease (VBD) risks in Europe

A reminder for travellers of the risk of vector-borne diseases in Europe this summer

Updated: 10 July 2025
Take usual precautions

Outbreaks

Using information collated from a variety of sources, we regularly review and update information on overseas disease outbreaks and other health issues that may affect the UK traveller.

Please note that not all cases of disease or outbreaks are reported; some diseases may only be reported if they occur outside of the usual recognised risk area or season, or they have been reported in greater than usual numbers.

Further information on the Outbreak Surveillance section.

 


13 October 2026

Dengue in Italy

As of 8 October 2026, the Italian authorities confirmed the 68 locally acquired dengue cases reported for 2026 were in the following regions: Campania (2), Lazio (1), Lombardy (2), Puglia (20), Tuscany (36) and Veneto (7). Please see our Topics in Brief article for further details on dengue.

Take usual precautions
Outbreak updates (latest first)

As of 7 October 2026, a total of 68 confirmed locally acquired dengue cases have been reported for 2026 in Italy. Please see our Topics in Brief article for further details on dengue.

Source: ECDC
TuscanyPugliaVenetoLombardyCampania

As of 29 September 2026, a total of 59 confirmed locally acquired dengue cases have been reported for 2026 in Italy. Please see our Topics in Brief article for further details on dengue.

Source: State
TuscanyPugliaLombardyCampania

As of 22 September 2026, a total of 47 confirmed locally acquired dengue cases have been reported for 2026 in Italy. The cases have been reported in Puglia (13), Tuscany (31), Lombardy (2), Campania (1) regions of Italy. Please see our Topics in Brief article for further details on dengue.

Source: State
TuscanyPuglia

As of 8 September 2026, a total of 24 confirmed locally acquired dengue cases have now been reported for 2026 in the Puglia and Tuscany regions of Italy. Please see our Topics in Brief article for further details on dengue.

Source: State
TuscanyPuglia

As of 30 August 2026, a total of three confirmed locally acquired dengue cases have been reported during 2026 in the Puglia and Tuscany regions of Italy. Please see our Topics in Brief article for further details on dengue.

Source: State

16 September 2026

Usutu virus in Italy

As of 9 September 2026, a total of 12 Usutu virus cases have been reported in six regions of Italy during 2026. Of these, seven have been reported in Lombardy, and one case has been reported in each of Emilia-Romagna, Veneto, Marche, Lazio and Piedmont.

Take usual precautions
Outbreak updates (latest first)

As of 26 August 2026, a total of 10 Usutu virus cases have been reported in five regions of Italy during 2026.

Source: State
Emilia-RomagnaLazioMarcheLombardy

As of 12 August 2026, a total of eight Usutu virus cases have been reported in four regions of Italy during 2026.

Source: State
Lombardy

As of 28 July 2026, three cases of Usutu virus have been reported in Lombardy, Italy during 2026.

Source: State

14 September 2026

West Nile virus in Italy

As of 10 September 2026, a total of 590 locally acquired human cases of West Nile virus have been reported in Italy during 2026. Please see our Topics in Brief article for further details on West Nile virus.

Take usual precautions
Outbreak updates (latest first)

As of 12 August 2026, a total of 224 locally acquired cases of West Nile virus, with seven deaths (one in an imported case), have now been reported from 55 provinces in 16 regions of Italy during 2026. Please see our Topics in Brief article for further details on West Nile virus.

Source: State

As of 5 August 2026, 139 locally acquired cases of West Nile virus have been reported in 50 provinces in Italy. Please see our Topics in Brief article for further details on West Nile virus.

Source: State

As of 29 July 2026, 94 locally acquired cases of West Nile virus have been reported in 30 areas in Italy. Please see our Topics in Brief article for further details on West Nile virus.

Source: ECDC

As of 17 July 2026, a total of 21 cases of West Nile Virus have been reported in Italy. Please see our Topics in Brief article on West Nile virus.

Source: ECDC

10 September 2026
Italy + Rome

Chikungunya in Italy

As of 4 September 2026, the first locally acquired case of chikungunya for 2026 has been confirmed in the municipality of Rome in Italy. Please see our Topics in Brief article for further details on chikungunya.

Take usual precautions

01 September 2026
Italy + Palermo

Diphtheria in Italy

On 20 August 2026, a fatal case of diphtheria has been confirmed in a child in Palermo, Sicily. A second probable case has been reported in another child who is unwell and is a contact of the first case. A further ten family members are reported to have tested positive, but remain well. Please see our Topics in Brief article for further details on diphtheria.

Take usual precautions

Rabies in Italy ex Morocco

On 29 May 2026 health authorities reported detection of rabies in a dog in Vittorio Veneto, Italy. The dog had been imported illegally from Morocco. Authorities announced mandatory rabies vaccination for all dogs and cats in the municipality. Please see our Topics in Brief article for further details on rabies.

Take usual precautions

Influenza A(H9N2) in Italy ex Senegal

On 10 April 2026, the World Health Organization reported the first imported human case of avian influenza A(H9N2) in Italy. The case was in an adult returning from Senegal. This is also the first imported human case of avian influenza A(H9N2) reported in the European Region. Please see our Topics in Brief article for further details on avian influenza.

Take usual precautions

20 March 2026
Italy + Campania

Hepatitis A in Italy

As of 19 March 2026 there have been 65 cases of hepatitis A confirmed in the Campania region, which includes the cities of Naples and Capri. It appears that the cases are connected to the consumption of infected seafood. Please see our Topics in Brief article for further details on hepatitis A.

Take usual precautions

12 November 2025
Italy + Tuscany
Emilia-Romagna
Veneto
Basilicata

Chikungunya in Italy

As of 4 November 2025, a total of 374 locally acquired chikungunya cases have been identified in four regions of Italy in 2025: Emilia-Romagna, Veneto, Tuscany, and Basilicata. The largest outbreak (316 confirmed cases) is located primarily in the province of Modena (Emilia-Romagna). Please see our Topics in Brief article for further details on chikungunya.

Take usual precautions
Outbreak updates (latest first)
TuscanyEmilia-RomagnaVeneto

As of 9 October 2025, a total of 353 locally acquired cases of chikungunya have been reported during 2025. Local transmission has been reported in three regions (Emilia-Romagna, Tuscany and Veneto). The largest outbreak (299 confirmed cases) is located in the province of Modena (Emilia-Romagna). Please see our Topics in Brief article for further details on chikungunya.

Source: State

As of 30 September 2025, a total of 323 locally acquired cases of chikungunya have been reported during 2025. Local transmission has been reported in two regions (Emilia-Romagna and Veneto). The largest outbreak (207 confirmed cases) is located in the province of Modena (Emilia-Romagna). A smaller outbreak (50 confirmed cases) is located in the province of Verona (Veneto). Please see our Topics in Brief article for further details on chikungunya.

Source: State

As of 23 September 2025, a total of 268 locally acquired cases of chikungunya have been reported during 2025. Local transmission has been reported in the regions of Emilia-Romagna and Veneto. The largest outbreak is ongoing in Moderna (Emilia-Romagna) reporting 216 confirmed cases. Please see our Topics in Brief article for further details on chikungunya.

Source: State

As of 17 September 2025, a total of 205 locally acquired cases of chikungunya have been reported this year. Three clusters are currently active. The largest cluster is located in Carpi, San Prospero, Soliera, Novellara, and Cavezzo (Emilia-Romagna region). Please see our Topics in Brief article for further details on chikungunya.

Source: ECDC

As of 11 September 2025, a total of 167 locally acquired chikungunya cases have been reported in Italy since the beginning of 2025. The cases were detected in Emilia Romagna and Veneto. Please see our Topics in Brief article for further details on chikungunya.

Source: State

As of 3 September 2025, Italy has now reported a total of 107 locally acquired chikungunya cases in 2025. The highest number of cases (85) is currently reported in Carpi, San Prospero and Soliera. Please see our Topics in Brief article for further details on chikungunya.

Source: ECDC

As of 27 August 2025, Italy has now reported a total of 63 locally acquired chikungunya cases in 2025. The highest number of cases (53) is currently reported in Modena province, Emilia-Romagna. Please see our Topics in Brief article for further details on chikungunya.

Source: ECDC
Emilia-RomagnaVeneto

As of 20 August 2025, a total of 29 locally acquired cases of chikungunya have been reported since the beginning of 2025. Cases have been reported from the regions of Emilia-Romagna and Veneto. Please see our Topics in Brief article for further details on chikungunya

Source: ECDC

As of 12 August 2025, Italy has now reported a total of seven locally acquired cases of chikungunya. Please see our Topics in Brief article for further details on chikungunya.

Source: State

On 7 August 2025, Italy has reported two new locally acquired cases of chikungunya. These are the first cases detected in Veneto. Please see our Topics in Brief article for further details on chikungunya.

Source: State
Bologna

As of 30 July 2025, Italy has reported a second locally acquired chikungunya case in the province of Bologna. Please see our Topics in Brief article for further details on chikungunya.

Source: ECDC
Emilia-Romagna

As of 15 July 2025, Italian health authorities have reported the first locally acquired case of chikungunya of the year. This case was reported in the Emilia Romagna region. A further 50 imported cases of the disease have been recorded in a number of regions. Please see our Topics in Brief article for further details on chikungunya.

Source: State

29 October 2025

Tick-borne encephalitis in Italy

As of 21 October 2025, a total of 48 tick-borne encephalitis cases (45 locally acquired) and one death have been reported in Italy in 2025. Please see our Topics in Brief article for further details on tick-borne encephalitis.

Take usual precautions

24 October 2025

Mpox in Italy

As of 24 October 2025, four confirmed cases of clade Ib mpox have been reported from Italy. Of these cases, one had no history of recent travel and is the first locally acquried case of mpox clade Ib reported from Italy. Please see our Topics in Brief article for further details on mpox.

Take extra precautions
Outbreak updates (latest first)

As of 27 June 2025, the World Health Organization reported an imported clade Ib mpox case in an adult with a recent history of travel to Tanzania. This is the first confirmed clade Ib mpox case reported in Italy. Please see our Topics in Brief article for further details on mpox.

Source: WHO

03 October 2025

West Nile virus in Italy

As of 1 October 2025, a total of 718 confirmed cases of West Nile virus, including 49 deaths have been reported across Italy in 2025. The most affected regions are Lazio (252 cases), Campania (124 cases) and Veneto (91 cases). Please see our Topics in Brief article for further details on West Nile virus.

Take usual precautions
Outbreak updates (latest first)

As of 3 September 2025, a total of 502 confirmed human cases of West Nile Virus infection have been reported this year. Among the confirmed cases, 33 deaths have been reported. Please see our Topics in Brief article for further details on West Nile virus.

Source: State

As of 27 August 2025, a total of 430 cases of West Nile virus infection (including 27 deaths) have now been confirmed in Italy since the beginning of 2025. Lazio remains the most affected region. Please see our Topics in Brief article for further details on West Nile virus.

Source: State

As of 13 August 2025, a total of 351 cases of West Nile virus infection (including 22 deaths) have now been confirmed in Italy since the beginning of 2025. Lazio is the most affected region (174 cases), followed by Campania (78 cases) and Veneto (36 cases). Please see our Topics in Brief article for further details on West Nile virus.

Source: State

As of 13 August 2025, a total of 275 cases of West Nile virus infection (including 19 deaths) have now been confirmed in Italy since the beginning of 2025. A total of 102 new cases were reported between 7 and 13 August 2025. Lazio region remains the most affected region, with 140 cases. Please see our factsheet for further details on West Nile virus.

Source: State

As of 6 August 2025, 173 confirmed human cases of West Nile virus (WNV) infection including 11 deaths have been reported across Italy since the beginning of 2025. This is an addition of 84 new cases cases since the last report on 30 July 2025. Lazio (Latina province) is the most affected region, followed by Campania and Veneto. Please see our factsheet for further details on West Nile virus.

Source: State
Emilia-RomagnaLazioVenetoLombardyPiedmontCampaniaSardegna

As of 31 July 2025, a total of 89 cases of West Nile virus infection (including eight deaths) have now been confirmed in Italy since the beginning of 2025. A total of 57 new cases were reported between 24 and 30 July 2025. Latina province, in Lazio region, has reported the highest number (54) of cases. Please see our factsheet for further details on West Nile virus.

Source: State

As of 23 July 2025, a total of 32 cases of West Nile virus infection (including two deaths) have been confirmed in Italy since the beginning of 2025. Of these cases, 21 were reported in the province of Latina, in the region of Lazio. Please see our factsheet for further details on West Nile virus.

Source: State

As of 20 July 2025, 10 confirmed human cases of West Nile virus have been reported since the beginning of 2025. Seven of these cases were reported from the Lazio region of Latina. Please see our factsheet for further details on West Nile virus.

Source: State

29 September 2025

Toscana virus in Italy

As of 23 September 2025, a total of 95 locally acquired cases of Toscana virus (including one death) have been reported in Italy during 2025. The most affected regions have been Tuscany, Emilia-Romagna and Marche. Please see the following information from the ECDC for further details on Toscana virus.

Take usual precautions

08 August 2025

Dengue in Italy

As of 5 August 2025, 111 confirmed cases of dengue (4 locally acquired) were reported. Two of the locally acquired cases have been identified in Emilia-Romagna and Veneto regions; further epidemiological investigations are in progress. Please see our Topics in Brief article for further details on dengue.

Take usual precautions
Outbreak updates (latest first)
Emilia-Romagna

As of 25 July 2025, three locally acquired cases of dengue have been reported in Italy. Please see our Topics in Brief article for further details on dengue.

Source: ECDC
Emilia-Romagna

As of 15 July 2025, Italian health authorities have reported the first locally acquired case of dengue of the year. This case was reported in the Emilia Romagna region. A further 82 imported cases of the disease have been recorded in a number of regions. Please see our Topics in Brief article for further details on dengue.

Source: State
TuscanyEmilia-RomagnaMarcheVenetoLombardyAbruzzo

As of 7 November 2024, 213 locally acquired-dengue cases have been reported in Italy. Cases have been reported from Abruzzo, Emilia Romagna, Lombardy, Marche, Tuscany, Veneto. Please see our Topics in Brief article for further details on dengue.

Source: ECDC
TuscanyEmilia-RomagnaMarcheVenetoLombardyAbruzzo

As of 24 October 2024, a total of 200 locally acquired dengue cases have been reported in Italy since the start of 2024. A total of 136 cases have now been confirmed as dengue virus type 2 (DENV-2) in the Marche Region.

Source: State
TuscanyEmilia-RomagnaMarcheVenetoLombardyAbruzzo

As of 8 October 2024, a total of 173 locally acquired dengue cases have been reported in Italy since the start of 2024.

Source: State
TuscanyEmilia-RomagnaMarcheVenetoLombardyAbruzzo

As of 3 October 2024, a total of 130 locally acquired dengue cases have been reported in Italy since the start of 2024. A total of 102 cases have now been confirmed as dengue virus type 2 (DENV-2) in the Marche Region. Sporadic cases of locally acquired DENV type 1, 2 and 3 continue to be reported in Abruzzo, Emilia-Romagna, Lombardy, Tuscany and Veneto regions.

Source: State
TuscanyEmilia-RomagnaMarcheVenetoLombardyAbruzzo

As of 24 September 2024, a total of 64 locally acquired dengue cases have been reported in Italy since the start of 2024. A total of 51 cases have now been confirmed as dengue virus type 2 (DENV-2) in the Marche Region. Sporadic cases of locally acquired DENV type 1, 2 and 3 continue to be reported in Abruzzo, Emilia-Romagna, Lombardy, Tuscany and Veneto regions.

Source: State
TuscanyEmilia-RomagnaMarcheLombardyAbruzzo

As of 19 September 2024, a total of 25 locally acquired dengue cases have been reported in Italy since the start of the year. A total of 20 cases were confirmed as dengue virus type 2 (DENV-2) in the Marche Region. Sporadic cases of locally acquired DENV type 1, 2 and 3 were reported in Abruzzo, Emilia-Romagna, Tuscany and Lombardy Regions.

Source: State
Emilia-RomagnaLombardy

As of 13 September 2024, two locally acquired cases of dengue have been reported in 2024 from Emilia-Romagna and Lombardy regions.

Source: State
Reggio Emilia

On 22 August 2024, the provincial health authorities have reported the first locally-acquired case of dengue in the municipality of Albinea, Reggio Emilia province. The case had not reported any foreign travel, however lives with family members that have recently returned from travel in East Asia.

Source: State